Skip to main content
. 2008 Aug 18;10(4):R94. doi: 10.1186/ar2478

Table 1.

Source and description of samples used in the study

Sample source Disease Number Female, no. (%) Age (range) anti-CCP positive, no. (%) RF positive, no. (%)
Dr. P. Gregersen, plasma set 1 RA 30 28 (93) 72.6 (51 to 89) 20 (67) 24 (80)
Healthy 10

Dr. P. Gregersen, plasma set 2 IBD 20 13 (65) 46.4 (23 to 82)
JRA 20 16 (80) 37.3 (10 to 71) 6 (30) 6 (30)
PsA 14 11 (79) 52.6 (23 to 75)
PS 20 10(50) 55.3(22 to 86)
RA 20 19(95) 59.0(35 to 89)
SLE 20 13 (65) 51.3 (29 to 67)

CCP, cyclic-citrullinated peptides; RF, rheumatoid factor; RA, rheumatoid arthritis; IBD, inflammatory bowel disease; JRA, juvenile rheumatoid arthritis; PsA, psoriatic arthritis; PS, psoriasis; SLE, systemic lupus erythematosus.